U.S. FDA Approves Simponi (golimumab) for the Treatment of Pediatric Ulcerative Colitis

Oct 9, 2025 - 11:00
 0  1
HORSHAM, Pa. (October 7, 2025) – Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Simponi (golimumab) for the treatment of children living with moderately to severely active ulcerative...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0